SCHEMBL25148162

SCHEMBL25148162

Nc1nc(Cl)nc(Oc2c(F)cccc2F)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.67
SMN1; SMN2 Q16637 5/20 0.33
KDM4E B2RXH2 3/20 0.33
RAB9A P51151 2/20 0.33
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DHPS P49366 1/20 0.32
PKM P14618 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ADORA2A P29274 1/20 0.31
DHFR P00374 2/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
HPGD P15428 1/20 0.31
DCPS Q96C86 1/20 0.31
SLC6A2 P23975 2/20 0.30
NPC1 O15118 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25147660 0.78 HSP90AA1 (0.52) HSP90AA1SMN1; SMN2RAB9AALDH1A1L3MBTL1
SCHEMBL16415975 0.71 SLC6A2 (0.45) SLC6A2HTR1A
SCHEMBL9371356 0.70 HSP90AA1 (0.54) HSP90AA1SMN1; SMN2KDM4ERAB9AALDH1A1
SCHEMBL17156499 0.70 HRH4 (0.50) HSP90AA1SMN1; SMN2KDM4ERAB9AALDH1A1
SCHEMBL870736 0.70 HSP90AA1 (0.54) HSP90AA1RAB9AALDH1A1MEN1KMT2A
SCHEMBL5939965 0.69 HSP90AA1 (0.53) HSP90AA1SMN1; SMN2RAB9AALDH1A1MEN1
SCHEMBL11040381 0.69 HSP90AA1 (0.53) HSP90AA1SMN1; SMN2KDM4ERAB9AALDH1A1
SCHEMBL22534769 0.68 MEN1 (0.45) HSP90AA1KDM4EMEN1KMT2ASLC6A2
SCHEMBL18173902 0.67 HSP90AA1 (0.47) HSP90AA1SMN1; SMN2KDM4ERAB9ANPSR1
SCHEMBL28442014 0.66 HSP90AA1 (0.49) HSP90AA1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034112-A1 IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE UNIV YALE (US) 2025-01-30 US disclosed
WO-2023064458-A1 SELECTIVE JAK2 INHIBITORS AND METHODS OF USE YALE UNIVERSITY (US) 2023-04-20 WO disclosed
WO-2023064458-A1 SELECTIVE JAK2 INHIBITORS AND METHODS OF USE YALE UNIVERSITY (US) 2023-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034112-A1 IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE JAK2, JAK1, MCL1 HSP90AA1 1488/4885SMN1; SMN2 3674/4885KDM4E 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.